作为HIV-1逆转录酶抑制剂,TARRNA选择性向鲁 (II) 复合体:关于探索多个位置的结构-活性关系
Meng Liu1, Dan-Dan Xie1, Yuan-Xiao Guo1
1Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650050, PR China.
Journal of inorganic biochemistry
|July 17, 2024
概括
新的 ((II) 复合物选择性地与HIV-1 TAR RNA结合,阻断病毒复制和Tat蛋白相互作用. 这些稳定,低毒性化合物为艾滋病毒和其他病毒性疾病提供了潜在的药物设计策略.
科学领域:
- 无机化学 无机化学 有机化学
- 生物化学 生化学
- 药用化学 医学化学
背景情况:
- 艾滋病毒-1逆转录酶 (RT) 抑制剂对于治疗艾滋病毒感染至关重要.
- 艾滋病毒-1 Tat 蛋白与 TAR RNA 相互作用,促进病毒转录.
- 针对Tat-TARRNA相互作用是开发新型抗病毒疗法的关键策略.
研究的目的:
- 设计和合成具有对HIV-1 TAR RNA有选择性结合亲和力的新型多二 (Ruthenium) 复合物.
- 研究这些复杂物与TAR RNA的分子相互作用和结合机制.
- 评估这些复合物作为HIV-1复制和Tat-TARRNA相互作用的抑制剂的潜力.
主要方法:
- 合成一个 4x6 复合物聚二 Ru (II) 复合物的库.
- 量子化学计算 (自然电荷群,静电潜力) 来预测TAR结合.
- 谱分析以确认TAR RNA结合并评估复合稳定性.
- 在体外测试以评估抑制Tat-TARRNA相互作用和HIV-1RT活性.
- 在正常细胞上进行细胞毒性测定.
主要成果:
- 一系列Ru(II) 复合物被合成,其中的特定修改增强了TAR RNA结合.
- 复合体a3 (R1=OH,R2=H,R3=Me) 通过键和静电吸引力证明了对HIV-1 TAR RNA的强有力的和选择性的结合.
- 这些复合物有效地抑制了TAR RNA和Tat蛋白之间的相互作用.
- 观察到HIV-1逆转录酶活性的抑制.
- 这些复合物表现出化学和光稳定性,选择性光谱反应和对正常细胞的低毒性.
结论:
- 聚氨酸Ru (II) 复合物可以被设计为可选择性地结合HIV-1 TAR RNA,破坏重要的病毒过程.
- 开发的复合物显示出作为抗艾滋病毒新型治疗剂的前景.
- 这项研究为开发无机过渡金属复合物作为治疗艾滋病毒和其他病毒性疾病 (HCV,EBOV,SARS-CoV-2) 的药物提供了基础.
- 这项研究有助于理解无机复合物和生物分子之间的基本相互作用.
相关概念视频
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K


